NR1D1 and colitis: Interestingly, an agonist of NR1D1 attenuates both dextran sodium sulfate (DSS)-induced colitis and D-galactosamine-induced fulminant hepatitis suggesting that NR1D1-mediated circadian control of Nlrp3 expression controls inflammation in vivo [45,46].